ARTICLE | Clinical News
Eucrisa regulatory update
December 15, 2016 11:19 PM UTC
FDA approved an NDA from Pfizer for Eucrisa crisaborole 2% ointment to treat mild to moderate atopic dermatitis in patients ages ≥2. Pfizer said the company plans to launch Eucrisa by the end of Janua...
BCIQ Company Profiles
BCIQ Target Profiles